Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Resulting concentration: Calculated or confirmed via the chart
Complementary work has documented activation of the VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) pathway, involved in angiogenesis, along with upregulation of early growth response genes (Egr-1) and the FAK-paxillin transcription factor in studied endothelial cells
DOI:10.3389/fphar.2021.627533 4.Kopjar.I, Milic.N, Sirovina.M, Mise.D, Protective and Reparative Effect of Petadecapeptide BPC 157 on Mice Blood, Liver and Kidney Cells
PubMed PMID 40005999 2025 literature and patent review discussing proposed biological activities and the lack of sufficient comprehensive clinical evidence
Potential benefits of AOD-9604: Targeted fat loss Improved body composition Minimal hormonal effects Low incidence of systemic side effects AOD-9604 is generally viewed as a body-composition peptide rather than a major weight-loss medication
US$ 21.79
US$ 21.38
US$ 28.11
:max_bytes(150000):strip_icc()/VWH-AmeliaManley-OzempicvsWegovyvsMounjaro-dc80b8c8de6243ec9b984cd4b5db5db4.jpg)
